The purpose of this study is to assess the comfort of a glaucoma therapy in patients with open-angle glaucoma or ocular...
Date First Received: May 12, 2006
Last Updated: December 19, 2007
Verified by: Alcon Research, September 2007
Clinical Trial Phase: Phase 2 | Start Date: April 2006
Overall Status: Completed
Estimated Enrollment: 88
Brief Summary
Official Title: “A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension”
Condition Keyword(s):
Intervention(s):
The purpose of this study is to assess the comfort of a glaucoma therapy in patients with open-angle glaucoma or ocular hypertension
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Intervention(s) in this Clinical Trial
- Drug: Brinzolamide/Timolol
Outcome Measures for this Clinical Trial
Primary Measures
- Ocular discomfort
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Adults of either sex and any race diagnosed with open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component)
Exclusion Criteria:
- Under 18
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: N/A
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Sponsor Information
Lead Sponsor: Alcon Research
Overall Clinical Trial Officials and Contacts
Julia White Study Director Study Director
Additional Information
Information obtained from ClinicalTrials.gov on July 02, 2009
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00326092
Study ID Number: C-05-49
ClinicalTrials.gov Identifier: NCT00326092
Health Authority: United States: Food and Drug Administration
Clinical Trials Authorship and Review
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
